← Leaderboards
Emily Jessica Anglin
Spinnaker Biosciences, Inc.
$409,384
Attributed
$659,384
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $427.1K · FY2014–15$500K$375K$250K$125K$0
'14
'15
Funding mix
By agency
FDA$500,000 · 1
NIH$159,384 · 1
By mechanism
U01$500,000 · 1
R41$159,384 · 1
Top collaborators
- Michael J Sailor2 shared
Others in their field
Top investigators on “Age Related Macular Degeneration”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Rohit Varma · University Of Southern California$50,124,787
- Maureen G Maguire · University Of Pennsylvania$38,506,792
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Krzysztof Palczewski · University Of California-Irvine$27,513,979
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
Age Related Macular DegenerationAntibodiesAnti-InflammatoryAnti-Inflammatory AgentsBaseBevacizumabBlood VesselsCaliberCaliforniaChemistryChronicClinical TrialsCostDesign And ConstructionDigestionDimensionsDisease ProgressionDoxorubicinDrug Delivery SystemsDrug FormulationsDrug KineticsDrug ProductionEffective TherapyAffect
Grant awards (3)
Modeling of the vitreous for in vitro prediction of drug delivery of porous silicon particles and episcleral plaques$232,279
U01 · FY2015 · FD
Modeling of the vitreous for in vitro prediction of drug delivery of porous silicon particles and episcleral plaques$267,721
U01 · FY2014 · FD
Manufacture of Self-Reporting, Drug Loaded Porous Silicon Nanomaterials for Treat$159,384
R41 · FY2014 · EY · contact PI